Form 4: National Research Corp Director Acquires Stock Options

Sentiment:

SEC Form 4 Filing


Director Stephen H. Lockhart acquired 34,917 stock options in National Research Corp on May 7, 2025, as part of an annual grant.

Summary

  • Stephen H. Lockhart, a director at National Research Corporation, reported a transaction on May 7, 2025.
  • Lockhart acquired 34,917 stock options with an exercise price of $13.09.
  • These options were granted under the Issuer's 2025 Omnibus Incentive Plan.
  • The options vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, and expire on May 7, 2035.
  • Following the transaction, Lockhart directly owns 34,917 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a standard transaction (stock option grant) that aligns director interests with shareholders, which is generally viewed favorably.

Positives

  • The grant of stock options to a director aligns their interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the director.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting and expiration of the stock options.

Industry Context

This is a standard SEC Form 4 filing, reflecting a common practice of granting stock options to company directors as part of their compensation package. It's typical for companies to use stock options to incentivize directors and align their interests with shareholders.

Comparison to Industry Standards

  • Stock option grants to directors are a common practice across publicly traded companies.
  • The vesting schedule and exercise price are typical components of such grants, designed to incentivize long-term performance.
  • Companies like Oracle, Microsoft, and Apple also grant stock options to their directors as part of their compensation packages.

Stakeholder Impact

  • The stock option grant aligns the director's interests with those of the shareholders, potentially leading to better corporate governance and increased shareholder value.

Next Steps

  • The options will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting.

Key Dates

DateDescription
05/07/2025Date of transaction: Stephen H. Lockhart acquired stock options.
05/09/2025Date of signature on the Form 4 filing.
05/07/2035Expiration date of the stock options.

Keywords

stock options, director, National Research Corporation, Lockhart, Form 4, beneficial ownership, derivative securities, Omnibus Incentive Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.